THK (6481) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Mar, 2026Executive summary
Revenue for the nine months ended September 30, 2024, was ¥265,130 million, down 1.1% year-over-year amid global economic uncertainty and a high prior-year order backlog.
Operating income declined 32.7% year-over-year to ¥12,919 million, with margin dropping to 4.9% due to higher SGA expenses and a rise in cost-to-revenue ratio.
Profit attributable to owners of the parent fell 34.7% year-over-year to ¥9,190 million; basic EPS was ¥74.96, down from ¥114.81.
Financial highlights
Gross profit for the nine months was ¥60,499 million, down from ¥62,240 million year-over-year.
SGA expenses increased 9.2% to ¥48,279 million, raising the SGA-to-revenue ratio to 18.2%.
Total assets decreased to ¥547,172 million from ¥556,351 million at the previous fiscal year-end, mainly due to lower cash and cash equivalents.
Total equity rose to ¥373,083 million, driven by higher retained earnings and other equity components.
Net cash provided by operating activities was ¥20,317 million, while investing activities used ¥24,935 million and financing activities used ¥18,292 million.
Outlook and guidance
Full-year 2024 revenue forecast is ¥350,000 million (down 0.6% year-over-year), with operating income projected at ¥17,000 million (down 28.3%).
Profit attributable to owners of the parent is forecast at ¥12,100 million (down 34.2%), with projected EPS of ¥98.68.
Year-end dividend to be calculated based on a DOE of 4% for the half-year.
Latest events from THK
- Major loss from business transfer drives net loss, but strong FY2026 recovery forecast.6481
Q4 202518 Mar 2026 - Revenue and profit declined, but China and Asia showed growth as equity fell on buybacks.6481
Q2 202518 Mar 2026 - Revenue was stable but profit fell; FY2025 outlook expects strong profit recovery.6481
Q4 202418 Mar 2026 - Revenue and profit fell year-over-year, but recovery and new product initiatives support outlook.6481
Q2 202418 Mar 2026 - Profit plunged despite stable revenue, but full-year outlook and dividend were raised.6481
Q1 202518 Mar 2026 - Revenue up, but profits down sharply on higher costs and equity-method losses.6481
Q3 202511 Nov 2025